Myotonic dystrophy type 1: frequency of ophthalmologic findings

被引:11
|
作者
Ikeda, Karin Suzete [1 ]
Iwabe-Marchese, Cristina [2 ]
Franca, Marcondes Cavalcante, Jr. [2 ]
Nucci, Anamarli [2 ]
de Carvalho, Keila Monteiro [1 ]
机构
[1] Univ Estadual Campinas, Fac Ciencias Med, Dept Oftalmol, Campinas, SP, Brazil
[2] Univ Estadual Campinas, Fac Ciencias Med, Dept Neurol, Campinas, SP, Brazil
关键词
myotonic dystrophy type 1; cataract; eyelid ptosis; intraocular pressure; Motor Function Measure scale; Portuguese version; MOTOR FUNCTION; CTG REPEAT; CATARACT; GENE; EXPRESSION; SIX5; MICE;
D O I
10.1590/0004-282X20150218
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The purpose of the study was to evaluate the frequency of ophthalmologic abnormalities in a cohort of myotonic dystrophy type 1 (DM1) patients and to correlate them with motor function. We reviewed the pathophysiology of cataract and low intraocular pressure (IOP). Method: Patients were included after clinical and laboratory diagnosis and after signed informed consent. They were evaluated by Motor Function Measure scale, Portuguese version (MFM-P) and ophthalmic protocol. Results: We evaluated 42 patients aged 17 to 64 years (mean 40.7 +/- 12.5), 22 of which were men. IOP (n = 41) was reduced in all but one. We found cataract or positivity for surgery in 38 (90.48%) and ptosis in 23 (54.76%). These signs but not IOP were significantly correlated with severity of motor dysfunction. Abnormalities in ocular motility and stereopsis were observed. Conclusion: Cataract and ptosis are frequent in DM1 and associated to motor dysfunction. Reduced IOP is also common, but appears not to be related with motor impairment.
引用
收藏
页码:183 / 188
页数:6
相关论文
共 50 条
  • [31] Characteristic Mill findings of upper limb muscle involvement in myotonic dystrophy type 1
    Sugie, K.
    Sugie, M.
    Taoka, T.
    Tonomura, Y.
    Kumazawa, A.
    Izumi, T.
    Ueno, S.
    Kichikawa, K.
    NEUROMUSCULAR DISORDERS, 2015, 25 : S272 - S272
  • [32] Magnetic resonance imaging findings in adult-form myotonic dystrophy type 1
    Jakkani, Ravikanth
    Jyoti, Sureka
    Ahmed, Munawwar
    Thomas, Maya Mary
    SINGAPORE MEDICAL JOURNAL, 2012, 53 (07) : E150 - E152
  • [33] A patient with neurofibromatosis type 1 and myotonic dystrophy type 1
    Esra, Serdaroglu
    Ceren, Gunbey
    Banu, Anlar
    NEUROLOGY ASIA, 2022, 27 (02) : 503 - 506
  • [34] Transcranial brain parenchyma sonographic findings in patients with myotonic dystrophy type 1 and 2
    Mijajlovic, Milija
    Bozovic, Ivo
    Pavlovic, Aleksandra
    Rakocevic-Stojanovic, Vidosava
    Gluscevic, Sanja
    Stojanovic, Amalija
    Basta, Ivana
    Meola, Giovanni
    Peric, Stojan
    HELIYON, 2024, 10 (05)
  • [35] Editors' note: High frequency of gastrointestinal manifestations in myotonic dystrophy type 1 and type 2
    Karam, Chafic
    Galetta, Steven
    NEUROLOGY, 2018, 90 (17) : 813 - 813
  • [36] Author response: High frequency of gastrointestinal manifestations in myotonic dystrophy type 1 and type 2
    Hilbert, James E.
    Thornton, Charles A.
    Moxley, Richard T., III
    NEUROLOGY, 2018, 90 (17) : 814 - 815
  • [37] Imaging of the thymus in myotonic dystrophy type 1
    Mignarri, Andrea
    Gentili, Francesco
    Masia, Francesco
    Genua, Angelo
    Cenciarelli, Silvia
    Brunori, Paola
    Mazzei, Maria Antonietta
    Malandrini, Alessandro
    Federico, Antonio
    Mazzei, Francesco Giuseppe
    Dotti, Maria Teresa
    NEUROLOGICAL SCIENCES, 2018, 39 (02) : 347 - 351
  • [38] Pain in Myotonic Muscular Dystrophy, Type 1
    Carter, Gregory T.
    Jensen, Mark P.
    Hoffman, Amy J.
    Stoelb, Brenda L.
    Abresch, Richard T.
    McDonald, Craig M.
    ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION, 2008, 89 (12): : 2382 - 2382
  • [39] Cardiac abnormalities in myotonic dystrophy type 1
    Finsterer, J
    Stöllberger, C
    AMERICAN HEART JOURNAL, 2004, 148 (06)
  • [40] Molecular biomarkers in myotonic dystrophy type 1
    Slipsager, A.
    Hildonen, M.
    Stemmerik, M. Godtfeldt
    Tumer, Z.
    Duno, M.
    Birkedal, U.
    Vissing, J.
    NEUROMUSCULAR DISORDERS, 2023, 33 : S155 - S155